215 related articles for article (PubMed ID: 16144889)
1. Summaries for patients. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: U.S. Preventive Services Task Force recommendations.
Ann Intern Med; 2005 Sep; 143(5):I47. PubMed ID: 16144889
[No Abstract] [Full Text] [Related]
2. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: recommendation statement.
U.S. Preventive Services Task Force
Ann Intern Med; 2005 Sep; 143(5):355-61. PubMed ID: 16144894
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 25006622
[No Abstract] [Full Text] [Related]
4. Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
Ann Intern Med; 2014 Feb; 160(4):I-16. PubMed ID: 24366402
[No Abstract] [Full Text] [Related]
5. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility: systematic evidence review for the U.S. Preventive Services Task Force.
Nelson HD; Huffman LH; Fu R; Harris EL;
Ann Intern Med; 2005 Sep; 143(5):362-79. PubMed ID: 16144895
[TBL] [Abstract][Full Text] [Related]
6. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Moyer VA;
Ann Intern Med; 2014 Feb; 160(4):271-81. PubMed ID: 24366376
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement.
; Owens DK; Davidson KW; Krist AH; Barry MJ; Cabana M; Caughey AB; Doubeni CA; Epling JW; Kubik M; Landefeld CS; Mangione CM; Pbert L; Silverstein M; Simon MA; Tseng CW; Wong JB
JAMA; 2019 Aug; 322(7):652-665. PubMed ID: 31429903
[TBL] [Abstract][Full Text] [Related]
8. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Nelson HD; Pappas M; Cantor A; Haney E; Holmes R
JAMA; 2019 Aug; 322(7):666-685. PubMed ID: 31429902
[TBL] [Abstract][Full Text] [Related]
9. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
Nelson HD; Pappas M; Zakher B; Mitchell JP; Okinaka-Hu L; Fu R
Ann Intern Med; 2014 Feb; 160(4):255-66. PubMed ID: 24366442
[TBL] [Abstract][Full Text] [Related]
10. Taking family history seriously.
Burke W
Ann Intern Med; 2005 Sep; 143(5):388-9. PubMed ID: 16144898
[No Abstract] [Full Text] [Related]
11. Prevention and screening in BRCA mutation carriers and other breast/ovarian hereditary cancer syndromes: ESMO Clinical Practice Guidelines for cancer prevention and screening.
Paluch-Shimon S; Cardoso F; Sessa C; Balmana J; Cardoso MJ; Gilbert F; Senkus E;
Ann Oncol; 2016 Sep; 27(suppl 5):v103-v110. PubMed ID: 27664246
[No Abstract] [Full Text] [Related]
12. Hereditary Breast and ovarian cancer: providing personalized medicine.
Tranin AS
AWHONN Lifelines; 2005; 9(5):372-6. PubMed ID: 16359075
[No Abstract] [Full Text] [Related]
13. Improving surveillance and quality of life of BRCA mutation carriers.
Loman N; Borg A
J Clin Oncol; 2010 Aug; 28(22):e376-7. PubMed ID: 20458044
[No Abstract] [Full Text] [Related]
14. High-risk women should have BRCA testing.
Cancer Discov; 2014 Feb; 4(2):139. PubMed ID: 24501290
[TBL] [Abstract][Full Text] [Related]
15. Using genetic analysis to individualize preventive measures for breast and ovarian cancers.
Olopade OI
Nat Clin Pract Oncol; 2006 Apr; 3(4):182-3. PubMed ID: 16596140
[No Abstract] [Full Text] [Related]
16. The need for public education: "Surveillance and risk reduction strategies" for women at risk for carrying BRCA gene mutations.
Nisker JA
J Obstet Gynaecol Can; 2007 Jun; 29(6):510-1. PubMed ID: 17568484
[No Abstract] [Full Text] [Related]
17. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium.
Burke W; Daly M; Garber J; Botkin J; Kahn MJ; Lynch P; McTiernan A; Offit K; Perlman J; Petersen G; Thomson E; Varricchio C
JAMA; 1997 Mar; 277(12):997-1003. PubMed ID: 9091675
[TBL] [Abstract][Full Text] [Related]
18. Preconception counseling for the couple at risk preventing the hereditary breast and ovarian cancer syndrome.
Beller U
Int J Gynecol Cancer; 2010 Oct; 20(11 Suppl 2):S29-30. PubMed ID: 20975358
[No Abstract] [Full Text] [Related]
19. Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
Wolff TA; Wilson JE
Am Fam Physician; 2006 Nov; 74(10):1759-60. PubMed ID: 17137007
[No Abstract] [Full Text] [Related]
20. Choices--and uncertainties--for women with BRCA mutations.
Couzin J
Science; 2003 Oct; 302(5645):592. PubMed ID: 14576419
[No Abstract] [Full Text] [Related]
[Next] [New Search]